xB3-008

N/A

Report date: 2024/05/08 10:19:51

Base Information

Drug NamexB3-008
Drug Alias NamexB3-008xB-3-008BDX-108
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionIduronate-2-sulfatase replacements
TargetsIduronate-2-sulfatase
Therapy Area/IndicationsMucopolysaccharidosis II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioasis Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioasis Technologies Inc
Active IndicationsN/A
Inactive IndicationsMucopolysaccharidosis II

Other Information

ATC CodeN/A
Related LinksN/A